Craneware plc Blocklisting Application (3595B)
11 Fevereiro 2022 - 4:00AM
UK Regulatory
TIDMCRW
RNS Number : 3595B
Craneware plc
11 February 2022
Craneware plc
("Craneware" or the "Company")
Blocklisting Application
Craneware plc (AIM: CRW.L), the market leader in Value Cycle
software solutions for the US healthcare market, announces that a
block listing application has been made to the London Stock
Exchange for 200,000 ordinary shares of one pence each ("Ordinary
Shares") to be admitted to trading on AIM (the "Admission"). The
Ordinary Shares that are being reserved under this block listing
application will be issued by the Company, as required, in order to
satisfy the exercise of share options pursuant to the terms of the
following share plans:
Share plan Number of Ordinary
Shares
The Craneware plc SAYE Option Plan (2018) 100,000
-------------------
The Craneware plc Employee Stock Purchase
Plan (2018) 100,000
-------------------
Total 200,000
-------------------
It is expected that Admission of these Ordinary Shares will
become effective on 16 February 2022. When issued, the Ordinary
Shares will be credited as fully paid and will rank pari passu in
all respects with the existing Ordinary Shares.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Hilary Buchanan, Joe Pederzolli craneware@almapr.co.uk
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster, Andrew Clark, Lalit Bose
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff
About Craneware
We at the Craneware Group of companies, including our latest
additions Sentry Data Systems and Agilum Healthcare Intelligence,
passionately believe we can impact healthcare profoundly by
delivering the insights healthcare organizations need to also
transform the business of healthcare. Our shared vision is to be
the operational and financial partner for U.S. healthcare
providers.
Our combined suite of applications and industry-leading team of
experts help our customers contextualize operational, financial,
and clinical data, providing insights that clearly demonstrate what
great looks like. These value cycle insights deliver revenue
integrity and 340B compliance, as well as margin and operational
intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now
our customers, including more than 2000 U.S hospitals and health
systems and almost 10,000 clinics and retail pharmacies. Our
customers are operating with a financial impact of nearly half a
trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.
Learn more at craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSGPUWGPUPPGRU
(END) Dow Jones Newswires
February 11, 2022 02:00 ET (07:00 GMT)
Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025